Niemann-Pick Type C 1 (NPC1) and NPC2 Gene Variability in Demented Patients with Evidence of Brain Amyloid Deposition

被引：10

作者：

Sorrentino, Federica ^{[1
,2
]}

Arighi, Andrea ^{[1
]}

Serpente, Maria ^{[1
,2
]}

Arosio, Beatrice ^{[1
,2
]}

Arcaro, Marina ^{[1
]}

Visconte, Caterina ^{[1
]}

Rotondo, Emanuela ^{[1
]}

Vimercati, Roberto ^{[1
]}

Ferri, Evelyn ^{[1
]}

Fumagalli, Giorgio G. ^{[1
]}

Pietroboni, Anna M. ^{[1
]}

Carandini, Tiziana ^{[1
]}

Scarpini, Elio ^{[1
,2
]}

Fenoglio, Chiara ^{[2
]}

Galimberti, Daniela ^{[1
,2
]}

机构：

[1] Fdn IRCCS Ca Granda, Osped Policlin, Via Francesco Sforza 35, I-20122 Milan, Italy

[2] Univ Milan, Milan, Italy

来源：

JOURNAL OF ALZHEIMERS DISEASE | 2021年 / 83卷 / 03期

关键词：

Amyloid; cerebrospinal fluid; NPC1; NPC2; Niemann-Pick Type C; psychiatric onset; variability; DISEASE TYPE-C; ALZHEIMERS-DISEASE; DIAGNOSTIC-CRITERIA; BEHAVIORAL VARIANT; IDENTIFICATION; MUTATIONS;

D O I：

10.3233/JAD-210453

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Background: Variants in Niemann-Pick Type C genes (NPC1 and NPC2) have been suggested to play a role as risk or disease modifying factors for Alzheimer's disease (AD). Objective: The aim of this study was to analyze NPC1 and NPC2 variability in demented patients with evidence of brain amyloid-beta 1-42 (A beta) deposition and to correlate genetic data with clinical phenotypes. Methods: A targeted Next Generation Sequencing panel was customized to screen NPC1, NPC2, and main genes related to neurodegenerative dementias in a cohort of 136 demented patients with cerebrospinal fluid (CSF) low A beta levels or positive PET with A beta tracer and 200 non-demented geriatric subjects. Results: Seven patients were carriers of NPC variants in heterozygosis. Four of them displayed pathogenic variants previously found in NPC patients and one AD patient had a novel variant. The latter was absent in 200 non-demented elderly subjects. Five of seven patients (70%) exhibited psychiatric symptoms at onset or later as compared with 43% in non-carriers (p > 0.05). Conclusion: The frequency of NPC1 and NPC2 heterozygous variants in patients with CSF evidence of A beta deposition is higher than in the general population.

引用

收藏

页码：1313 / 1323

页数：11

相关论文

共 50 条

[41] Reduction of TMEM97 increases NPC1 protein levels and restores cholesterol trafficking in Niemann-pick type C1 disease cells [J].

Ebrahimi-Fakhari, Darius ;

Wahlster, Lara ;

Bartz, Fabian ;

Werenbeck-Ueding, Jennifer ;

Praggastis, Maria ;

Zhang, Jessie ;

Joggerst-Thomalla, Brigitte ;

Theiss, Susanne ;

Grimm, Dirk ;

Ory, Daniel S. ;

Runz, Heiko .

HUMAN MOLECULAR GENETICS, 2016, 25 (16) :3588-3599

[42] Attenuation of the Niemann-Pick type C2 disease phenotype by intracisternal administration of an AAVrh.10 vector expressing Npc2 [J].

Markmann, Sandra ;

Christie-Reid, Jasmine J. ;

Rosenberg, Jonathan B. ;

De, Bishnu P. ;

Kaminsky, Stephen M. ;

Crystal, Ronald G. ;

Sondhi, Dolan .

EXPERIMENTAL NEUROLOGY, 2018, 306 :22-33

[43] Functional analysis of Niemann-Pick disease type C family protein, NPC1a, in Drosophila melanogaster [J].

Bialistoky, Tzofia ;

Manry, Diane ;

Smith, Peyton ;

Ng, Christopher ;

Kim, Yunah ;

Zamir, Sol ;

Moyal, Victoria ;

Kalifa, Rachel ;

Schedl, Paul ;

Gerlitz, Offer ;

Deshpande, Girish .

DEVELOPMENT, 2019, 146 (10)

[44] Npc1 deficiency in the C57BL/6J genetic background enhances Niemann-Pick disease type C spleen pathology [J].

Parra, Julio ;

Klein, Andres D. ;

Castro, Juan ;

Gabriela Morales, Maria ;

Mosqueira, Matias ;

Valencia, Ilse ;

Cortes, Victor ;

Rigotti, Attilio ;

Zanlungo, Silvana .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 413 (03) :400-406

[45] Novel NPC1 mutations with different segregation in two related Greek patients with Niemann-Pick type C disease: molecular study in the extended pedigree and clinical correlations [J].

Bountouvi, Evangelia ;

Papadopoulou, Anna ;

Vanier, Marie T. ;

Nyktari, Georgia ;

Kanellakis, Spyridon ;

Michelakakis, Helen ;

Dinopoulos, Argyrios .

BMC MEDICAL GENETICS, 2017, 18

[46] NPC1 enables cholesterol mobilization during long-term potentiation that can be restored in Niemann-Pick disease type C by CYP46A1 activation [J].

Mitroi, Daniel N. ;

Pereyra-Gomez, Guadalupe ;

Soto-Huelin, Beatriz ;

Senovilla, Fernando ;

Kobayashi, Toshihide ;

Esteban, Jose A. ;

Dolores Ledesma, Maria .

EMBO REPORTS, 2019, 20 (11)

[47] NPC1-mTORC1 Signaling Couples Cholesterol Sensing to Organelle Homeostasis and Is a Targetable Pathway in Niemann-Pick Type C [J].

Davis, Oliver B. ;

Shin, Hijai R. ;

Lim, Chun-Yan ;

Wu, Emma Y. ;

Kukurugya, Matthew ;

Maher, Claire F. ;

Perera, Rushika M. ;

Ordonez, M. Paulina ;

Zoncu, Roberto .

DEVELOPMENTAL CELL, 2021, 56 (03) :260-+

[48] npc2-Deficient Zebrafish Reproduce Neurological and Inflammatory Symptoms of Niemann-Pick Type C Disease [J].

Wiweger, Malgorzata ;

Majewski, Lukasz ;

Adamek-Urbanska, Dobrochna ;

Wasilewska, Iga ;

Kuznicki, Jacek .

FRONTIERS IN CELLULAR NEUROSCIENCE, 2021, 15

[49] Ebola viral receptor Niemann–Pick C1 (NPC1) in human cancers: a potential biomarker and immunotherapeutic target [J].

Zhen Fang ;

Peijuan Li ;

Liang Shang ;

Fei Li .

Human Cell, 2022, 35 :423-426

[50] Quantitative Proteomics of Human Fibroblasts with I1061T Mutation in Niemann-Pick C1 (NPC1) Protein Provides Insights into the Disease Pathogenesis [J].

Rauniyar, Navin ;

Subramanian, Kanagaraj ;

Lavallee-Adam, Mathieu ;

Martinez-Bartolome, Salvador ;

Balch, William E. ;

Yates, John R., III .

MOLECULAR & CELLULAR PROTEOMICS, 2015, 14 (07) :1734-1749

← 1 2 3 4 5 →